Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims †

10.3390/toxins10120534

Saved in:

Bibliographic Details
Main Authors:	Kini, R.M, Sidhu, S.S, Laustsen, A.H
Other Authors:	BIOLOGICAL SCIENCES
Format:	Article
Published:	2020
Subjects:	biosynthetic oligoclonal antivenom enzyme inhibitor immunoglobulin G neutralizing antibody recombinant antibody single chain fragment variable antibody small molecule enzyme inhibitor snake venom snake venom antiserum unclassified drug monoclonal antibody recombinant protein venom antiserum allergic reaction anaphylaxis antibody production Article cross reaction drug efficacy drug potentiation drug safety fever geographical variation (species) human immunization morbidity mortality pathophysiology phage display pharmacodynamics protein expression serum sickness snakebite snakebite envenoming tissue injury animal Animals Antibodies, Monoclonal Antivenins Humans Recombinant Proteins Snake Bites
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/177804
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-177804
record_format	dspace
spelling	sg-nus-scholar.10635-1778042024-04-03T09:52:20Z Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims † Kini, R.M Sidhu, S.S Laustsen, A.H BIOLOGICAL SCIENCES biosynthetic oligoclonal antivenom enzyme inhibitor immunoglobulin G neutralizing antibody recombinant antibody single chain fragment variable antibody small molecule enzyme inhibitor snake venom snake venom antiserum unclassified drug monoclonal antibody recombinant protein venom antiserum allergic reaction anaphylaxis antibody production Article cross reaction drug efficacy drug potentiation drug safety fever geographical variation (species) human immunization morbidity mortality pathophysiology phage display pharmacodynamics protein expression serum sickness snakebite snakebite envenoming tissue injury animal snakebite Animals Antibodies, Monoclonal Antivenins Humans Recombinant Proteins Snake Bites 10.3390/toxins10120534 Toxins 10 12 534 2020-10-20T03:24:20Z 2020-10-20T03:24:20Z 2018 Article Kini, R.M, Sidhu, S.S, Laustsen, A.H (2018). Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims †. Toxins 10 (12) : 534. ScholarBank@NUS Repository. https://doi.org/10.3390/toxins10120534 20726651 https://scholarbank.nus.edu.sg/handle/10635/177804 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	biosynthetic oligoclonal antivenom enzyme inhibitor immunoglobulin G neutralizing antibody recombinant antibody single chain fragment variable antibody small molecule enzyme inhibitor snake venom snake venom antiserum unclassified drug monoclonal antibody recombinant protein venom antiserum allergic reaction anaphylaxis antibody production Article cross reaction drug efficacy drug potentiation drug safety fever geographical variation (species) human immunization morbidity mortality pathophysiology phage display pharmacodynamics protein expression serum sickness snakebite snakebite envenoming tissue injury animal snakebite Animals Antibodies, Monoclonal Antivenins Humans Recombinant Proteins Snake Bites
spellingShingle	biosynthetic oligoclonal antivenom enzyme inhibitor immunoglobulin G neutralizing antibody recombinant antibody single chain fragment variable antibody small molecule enzyme inhibitor snake venom snake venom antiserum unclassified drug monoclonal antibody recombinant protein venom antiserum allergic reaction anaphylaxis antibody production Article cross reaction drug efficacy drug potentiation drug safety fever geographical variation (species) human immunization morbidity mortality pathophysiology phage display pharmacodynamics protein expression serum sickness snakebite snakebite envenoming tissue injury animal snakebite Animals Antibodies, Monoclonal Antivenins Humans Recombinant Proteins Snake Bites Kini, R.M Sidhu, S.S Laustsen, A.H Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims †
description	10.3390/toxins10120534
author2	BIOLOGICAL SCIENCES
author_facet	BIOLOGICAL SCIENCES Kini, R.M Sidhu, S.S Laustsen, A.H
format	Article
author	Kini, R.M Sidhu, S.S Laustsen, A.H
author_sort	Kini, R.M
title	Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims †
title_short	Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims †
title_full	Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims †
title_fullStr	Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims †
title_full_unstemmed	Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims †
title_sort	biosynthetic oligoclonal antivenom (boa) for snakebite and next-generation treatments for snakebite victims †
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/177804
_version_	1795374440576450560

Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims †

Similar Items